NCAPG2 and hepatocellular carcinoma: Utilizing microarray technology in conjunction with a comprehensive analysis of the TCGA HCC datasets, we identified NCAPG2 as a downstream target positively regulated by RPL35A, and elevated NCAPG2 levels in HCC tissues were linked to poor prognosis.